• +1-646-491-9876
    • +91-20-67278686

    Search

    Psoriatic Arthritis Pipeline Review H1 2017

    Psoriatic Arthritis Pipeline Review H1 2017

    • Report Code ID: RW0001799283
    • Category Pharmaceuticals
    • No. of Pages 258
    • Publication Month May-17
    • Publisher Name Global Markets Direct
    Psoriatic Arthritis - Pipeline Review, H1 2017

    Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Psoriatic Arthritis - Pipeline Review, H1 2017, provides an overview of the Psoriatic Arthritis (Musculoskeletal Disorders) pipeline landscape.

    Psoriatic arthritis is a form of arthritis that affects some people who have psoriasis. Symptoms include swollen fingers and toes, foot pain and lower back pain. Risk factors include age, family history and psoriasis. Treatment includes NSAIDs, immunosuppressants and surgery.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Psoriatic Arthritis - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Psoriatic Arthritis (Musculoskeletal Disorders) , complete with analysis by stage of development, drug target, mechanism of action (MoA) , route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Psoriatic Arthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Psoriatic Arthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 8, 6, 9, 11, 2, 22, 7 and 4 respectively.

    Psoriatic Arthritis (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Psoriatic Arthritis (Musculoskeletal Disorders) .
    - The pipeline guide reviews pipeline therapeutics for Psoriatic Arthritis (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Psoriatic Arthritis (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Psoriatic Arthritis (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA) , drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Psoriatic Arthritis (Musculoskeletal Disorders)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Psoriatic Arthritis (Musculoskeletal Disorders) .
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Psoriatic Arthritis (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    Table of Contents 2
    Introduction 5
    Psoriatic Arthritis - Overview 6
    Psoriatic Arthritis - Therapeutics Development 7
    Psoriatic Arthritis - Therapeutics Assessment 16
    Psoriatic Arthritis - Companies Involved in Therapeutics Development 24
    Psoriatic Arthritis - Drug Profiles 43
    Psoriatic Arthritis - Dormant Projects 229
    Psoriatic Arthritis - Discontinued Products 231
    Psoriatic Arthritis - Product Development Milestones 232
    Appendix 250

    List of Tables

    Number of Products under Development for Psoriatic Arthritis, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..1) , H1 2017
    Number of Products under Development by Companies, H1 2017 (Contd..2) , H1 2017
    Products under Development by Companies, H1 2017
    Products under Development by Companies, H1 2017 (Contd..1) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..2) , H1 2017
    Products under Development by Companies, H1 2017 (Contd..3) , H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Psoriatic Arthritis - Pipeline by 3SBio Inc, H1 2017
    Psoriatic Arthritis - Pipeline by AbbVie Inc, H1 2017
    Psoriatic Arthritis - Pipeline by AbGenomics International Inc, H1 2017
    Psoriatic Arthritis - Pipeline by Adello Biologics LLC, H1 2017
    Psoriatic Arthritis - Pipeline by Allergan Plc, H1 2017
    Psoriatic Arthritis - Pipeline by Alteogen Inc, H1 2017
    Psoriatic Arthritis - Pipeline by Amgen Inc, H1 2017
    Psoriatic Arthritis - Pipeline by Biocon Ltd, H1 2017
    Psoriatic Arthritis - Pipeline by Bionovis SA, H1 2017
    Psoriatic Arthritis - Pipeline by Bristol-Myers Squibb Company, H1 2017
    Psoriatic Arthritis - Pipeline by Coherus BioSciences Inc, H1 2017
    Psoriatic Arthritis - Pipeline by Eli Lilly and Company, H1 2017
    Psoriatic Arthritis - Pipeline by Formycon AG, H1 2017
    Psoriatic Arthritis - Pipeline by Forward Pharma A/S, H1 2017
    Psoriatic Arthritis - Pipeline by Galapagos NV, H1 2017
    Psoriatic Arthritis - Pipeline by Genor BioPharma Co Ltd, H1 2017
    Psoriatic Arthritis - Pipeline by Immunwork Inc, H1 2017
    Psoriatic Arthritis - Pipeline by Innovent Biologics Inc, H1 2017
    Psoriatic Arthritis - Pipeline by Johnson & Johnson, H1 2017
    Psoriatic Arthritis - Pipeline by KPI Therapeutics Inc, H1 2017
    Psoriatic Arthritis - Pipeline by Merck KGaA, H1 2017
    Psoriatic Arthritis - Pipeline by Momenta Pharmaceuticals Inc, H1 2017
    Psoriatic Arthritis - Pipeline by Morphotek Inc, H1 2017
    Psoriatic Arthritis - Pipeline by Mycenax Biotech Inc, H1 2017
    Psoriatic Arthritis - Pipeline by Novo Nordisk A/S, H1 2017
    Psoriatic Arthritis - Pipeline by Nuevolution AB, H1 2017
    Psoriatic Arthritis - Pipeline by Oncobiologics Inc, H1 2017
    Psoriatic Arthritis - Pipeline by Panacea Biotec Ltd, H1 2017
    Psoriatic Arthritis - Pipeline by Pfizer Inc, H1 2017
    Psoriatic Arthritis - Pipeline by Prothena Corp Plc, H1 2017
    Psoriatic Arthritis - Pipeline by Reliance Life Sciences Pvt Ltd, H1 2017
    Psoriatic Arthritis - Pipeline by Sandoz International GmbH, H1 2017
    Psoriatic Arthritis - Pipeline by Sun Pharma Advanced Research Company Ltd, H1 2017
    Psoriatic Arthritis - Pipeline by SynAct Pharma AB, H1 2017
    Psoriatic Arthritis - Pipeline by UCB SA, H1 2017
    Psoriatic Arthritis - Pipeline by Valeant Pharmaceuticals International Inc, H1 2017
    Psoriatic Arthritis - Pipeline by Xbrane Biopharma AB, H1 2017
    Psoriatic Arthritis - Dormant Projects, H1 2017
    Psoriatic Arthritis - Dormant Projects, H1 2017 (Contd..1) , H1 2017
    Psoriatic Arthritis - Discontinued Products, H1 2017

    List of Figures

    Number of Products under Development for Psoriatic Arthritis, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products by Top 10 Targets, H1 2017
    Number of Products by Stage and Top 10 Targets, H1 2017
    Number of Products by Top 10 Mechanism of Actions, H1 2017
    Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
    Number of Products by Routes of Administration, H1 2017
    Number of Products by Stage and Routes of Administration, H1 2017
    Number of Products by Molecule Types, H1 2017
    Number of Products by Stage and Molecule Types, H1 2017
    3SBio Inc
    AbbVie Inc
    AbGenomics International Inc
    Adello Biologics LLC
    Allergan Plc
    Alteogen Inc
    Amgen Inc
    Biocon Ltd
    Bionovis SA
    Bristol-Myers Squibb Company
    Coherus BioSciences Inc
    Eli Lilly and Company
    Formycon AG
    Forward Pharma A/S
    Galapagos NV
    Genor BioPharma Co Ltd
    Immunwork Inc
    Innovent Biologics Inc
    Johnson & Johnson
    KPI Therapeutics Inc
    Merck KGaA
    Momenta Pharmaceuticals Inc
    Morphotek Inc
    Mycenax Biotech Inc
    Novo Nordisk A/S
    Nuevolution AB
    Oncobiologics Inc
    Panacea Biotec Ltd
    Pfizer Inc
    Prothena Corp Plc
    Reliance Life Sciences Pvt Ltd
    Sandoz International GmbH
    Sun Pharma Advanced Research Company Ltd
    SynAct Pharma AB
    UCB SA
    Valeant Pharmaceuticals International Inc
    Xbrane Biopharma AB

    Request for Sample

    Report Url http://www.reportsweb.com//psoriatic-arthritis-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//psoriatic-arthritis-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//psoriatic-arthritis-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments